NeurAxis Announces Q4 2024 Conference Call Invitation

Author: Kelly Martin Updated: 03-12-2025 09:00 AM

NeurAxis to Host Q4 and Full Year 2024 Results Conference Call

Carmel, Indiana – NeurAxis, Inc. (NYSE American: NRXS), a pioneering medical technology firm, is gearing up to present its financial results for the fourth quarter and the entire fiscal year of 2024. The announcement will take place on Thursday, prior to market opening. This exciting update will cover the performance data and strategic insights into the company's initiatives.

Details of the Conference Call

The financial results overview will be followed by a conference call on the same day, allowing interested parties to gain deeper insights into NeurAxis's performance. Here are the specifics:

Date and Time: Thursday, at 9:00 AM ET

For those unable to participate, a live webcast will be accessible via NeurAxis's Investor Relations webpage. This will facilitate a comprehensive engagement with the company’s progress.

Accessing the Webcast

To join the live conference call, participants can visit the Investor Relations section on the NeurAxis website. Queries can be submitted during the webcast using the designated link or can be directed to the company via email.

The direct link for the conference call will be provided upon registration, which ensures access to a unique PIN and dial-in information for seamless participation.

Replaying the Conference Call

A recording of the conference call will also be available on the company’s website shortly after the event, allowing stakeholders to revisit the insights shared during the session.

About NeurAxis, Inc.

NeurAxis is dedicated to innovating medical technology focused on neuromodulation therapies addressing chronic conditions that affect both children and adults. Their flagship IB-Stim™ therapy utilizes pioneering Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, which aims to improve the management of functional abdominal pain linked to irritable bowel syndrome (IBS) in adolescents aged 8-21.

With ongoing clinical trials investigating PENFS in broader pediatric and adult patient populations, NeurAxis is at the forefront of advancing healthcare solutions that cater to substantial unmet medical needs.

Frequently Asked Questions

What is NeurAxis, Inc. known for?

NeurAxis specializes in developing neuromodulation therapies aimed at treating chronic conditions in both children and adults.

When is the conference call scheduled?

The conference call is scheduled for Thursday at 9:00 AM ET.

How can I access the conference call?

Participants can join via a live webcast on the NeurAxis Investor Relations website or by registering for a dial-in option.

Is there a replay available?

Yes, the conference call will be available for replay on the NeurAxis website after the event.

What is the significance of IB-Stim™?

IB-Stim™ is a key therapy developed by NeurAxis, cleared by the FDA for treating functional abdominal pain associated with IBS in adolescents, marking a significant advancement in pediatric care.

About The Author

Hello Kelly Martin here, a financial and publicly traded company specialist committed to writing with clarity and sage advice. Having a wealth of experience and a thorough grasp of corporate dynamics and the financial environment, my main goal in writing blog posts and articles is to provide insightful analysis together with useful guidance. My objective is to arm readers with the information they need to comprehend the complexities of publicly traded companies and make wise financial decisions.

Writing for several financial blogs has let me interact with a wide range of readers, from novice investors to seasoned pros looking for fresh perspectives. My goal is to make corporate analysis and finance understandable and interesting so you may confidently negotiate the intricacies of the financial world. I appreciate you traveling with me toward success and financial literacy.

Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.